Buccal and Intranasal Delivery of Fospropofol

Case ID:
C14139

INVENTION NOVELTY

This invention provides for novel formulations and delivery methods of the propofol prodrug, fospropofol, allowing for its use in additional indications beyond anesthesia, including migraine, analgesia, and emesis treatment.


VALUE PROPOSITION

Propofol and its water soluble prodrug, fospropofol, are short-acting anesthetics used for general anesthesia. Propofol has shown efficacy in a number of additional indications, including migraine, analgesia, and emesis. However, current intravenous formulations of propofol and fospropofol do not allow for their exploration and use in these alternative indications due to their short-acting properties. These novel delivery methods allow for direct and sustained drug delivery, enabling their use beyond general anesthesia. Intranasal fospropofol delivery allows for direct delivery of the prodrug to the brain, while buccal delivery allows for a sustained release of propofol, These administration routes provide unique exposure profiles ideal for treatment of a variety of neurological and psychiatric conditions


TECHNICAL DETAILS

Propofol is only available in an IV formulation due to its water insolubility. The prodrug fospropofol is water soluble, making it amenable to alternative formulations. Unexpectedly, intranasal and buccal formulations of fospropofol result in significantly different pharmacokinetic profiles. Intranasal delivery leads to appreciable concentrations of fospropofol in the plasma and cerebral spinal fluid, suggesting direct delivery to the brain. Buccal delivery provides a controlled, sustained delivery of propofol, with drug concentrations slowly rising over several hours following administration; 50 mg buccal fospropofol resulted in >400 nM propofol plasma concentration in monkey models.

Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date Patent Status
BUCCAL, SUBLINGUAL AND INTRANASAL DELIVERY OF FOSPROPOFOL PCT: Patent Cooperation Treaty United States 16/304,800 11,331,271 11/27/2018 5/17/2022 5/25/2037 Granted
Inventors:
Category(s):
Get custom alerts for techs in these categories/from these inventors:
For Information, Contact:
Nakisha Holder
nickki@jhu.edu
410-614-0300
Save This Technology:
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum